Effectiveness of Tai Chi vs Cognitive Behavioural Therapy for Insomnia in Middle-Aged and Older Adults
November 27, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
N/A
Synonyms :
ficonalkibum, CT-3505, SY-3505, Ficonalkib
Class :
Antineoplastic agent
Brand Name :
N/A
Synonyms :
ficonalkibum, CT-3505, SY-3505, Ficonalkib
Class :
Antineoplastic agent
Dosage Forms & StrengthsÂ
Respiratory diseaseÂ
This drug is indicated in treating neoplasms and other diseases that are ALK-mediated.Â
It has completed Phase- 2 of clinical trials and entered Phase 3Â
This drug is indicated in treating neoplasms and other diseases that are ALK-mediated.
It has completed Phase- 2 of clinical trials and entered Phase 3
Dosage Forms & StrengthsÂ
Data not availableÂ
Refer to adult dosingÂ
Actions and SpectrumÂ
It acts by inhibiting the ALK-anaplastic lymphoma kinase which is a tyrosine kinase inhibitor.Â
Frequency not definedÂ
Information on adverse events is not availableÂ
Black Box Warning Â
No specific black box warnings are available for this drugÂ
Contraindication/Caution:Â
Contraindication:Â
No contraindications are available for this drug, as it is in phase-3 clinical trialsÂ
Pregnancy consideration:Â Â
Safety and efficacy study is not established in pregnant womenÂ
Lactation:Â Â
Safety and efficacy study is not established in lactating mothersÂ
Pregnancy category:Â Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
<b>Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
PharmacologyÂ
The exact pharmacology is not knownÂ
PharmacodynamicsÂ
It acts by inhibiting the tyrosine kinase inhibitor known as ALK-anaplastic lymphoma kinaseÂ
PharmacokineticsÂ
No data available on the ADMEÂ
AdministrationÂ
Under clinical trialsÂ
Patient information leaflet Â
Generic Name: ficonalkib  Â
Why do we use ficonalkib? Â
Ficonalkib is an anaplastic lymphoma kinase inhibitor undergoing phase 3 of clinical trials. This drug is being studied for its use in treating ALK-positive respiratory neoplasm.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
